Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Immune Responses to Vaccine”

Showing 20 of 0 results

Not applicableStudy completedNCT03743688
What this trial is testing

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaInfluenza, HumanVaccine Reaction+4 more
Vanderbilt University Medical Center 10
Early research (Phase 1)Study completedNCT00709605
What this trial is testing

Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Early research (Phase 1)Study completedNCT00991354
What this trial is testing

Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT00270218
What this trial is testing

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 66
Early research (Phase 1)Study completedNCT00119873
What this trial is testing

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT05446740
What this trial is testing

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 324
Early research (Phase 1)Study completedNCT05272605
What this trial is testing

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2
University of Melbourne 76
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Early research (Phase 1)Study completedNCT01915212
What this trial is testing

Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection

Who this might be right for
Healthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 69
Testing effectiveness (Phase 2)Study completedNCT05960097
What this trial is testing

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2COVID-19
GlaxoSmithKline 692
Early research (Phase 1)Study completedNCT03961438
What this trial is testing

Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine

Who this might be right for
HIV-1-infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24
Early research (Phase 1)Study completedNCT02231866
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 143
Testing effectiveness (Phase 2)Study completedNCT00192153
What this trial is testing

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older

Who this might be right for
Influenza
MedImmune LLC 240
Early research (Phase 1)Study completedNCT05613205
What this trial is testing

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Who this might be right for
Typhoid Fever
GlaxoSmithKline 97
Early research (Phase 1)UnknownNCT03600025
What this trial is testing

Cellular Immune Responses in Typhoid Fever Patients and Vaccinees

Who this might be right for
Typhoid Fever Patients and Healthy Volunteers to Receive Typbar-TCV Vaccine
International Centre for Diarrhoeal Disease Research, Bangladesh 30
Not applicableEnded earlyNCT01673425
What this trial is testing

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Who this might be right for
Influenza
National Center for Occupational Health and Infection Control 5
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Early research (Phase 1)Study completedNCT01549470
What this trial is testing

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Early research (Phase 1)Study completedNCT00384787
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation